Trial Profile
Evaluation of the pharmacokinetics of Atripla with and without food in HIV-1 infected Ugandan adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 14 Mar 2012 Planned end date (Feb 2010) added as reported by Pan-African Clinical Trials Registry record.
- 17 Sep 2011 New trial record